Emicizumab Use in Pediatric Patients in the Real World: an Analysis of the PedNet Registry

First published 27/11/2019

Last updated 25/06/2024

EU PAS number:

EUPAS31954

Study

Ongoing

Documents

Study protocol

Initial protocol

Prot MO40685 (PEDNET) emicizumab v1_Redacted

English (593.4 KB - PDF)View document

Updated protocol

MO40685 (PEDNET)-Protocol v2_Redacted

First published: 22/02/2024

English (284.5 KB - PDF)View document

Study results

Study report

Interim_CSR,_Study_MO40685_(PEDNET),_PASS_Annual_Report_30Sep2020,_Published_Output-1_Redacted

English (905.63 KB - PDF)View document

MO40685 (PEDNET)-Interim CSR Synopsis 2, PASS Annual Report_30Sep2021_Redacted

English (1.43 MB - PDF)View document

MO40685 (PEDNET)-Interim CSR Synopsis 3_PASS Annual Report_28Sep2022_Redacted

English (601.02 KB - PDF)View document

MO40685 (PEDNET)-Interim CSR Synopsis 4_Annual Report_29-Sep-2023_Redacted.pdf

English (629.55 KB - PDF)View document

Other information

ENCePP Seal

ENCePP Seal documents

Secondary tabs